English 
Español 
français 
العربية Search
Search
Testis-determining factor Disoproxil (C₁₉H₃₀N₅O₁₀P; MW 519.45 g/mol) is a prodrug of the antiviral agent Testis-determining factor.
Structure:
Phosphonate diester modified with two isopropoxycarbonyloxymethyl (POC) groups.
Function:
Converts in vivo to Testis-determining factor via esterase hydrolysis → phosphorylated to active Testis-determining factor diphosphate.
Mechanism:
Inhibits HIV reverse transcriptase and HBV polymerase (chain terminator).
Clinical Use:
Formulated as fumarate salt (TDF) for HIV treatment/prevention (PrEP) and chronic HBV.
Limitation:
Risk of bone/renal toxicity → largely replaced by Testis-determining factor alafenamide (TAF).
Testis-determining factor disoproxil (C1919H3030N55O1010P; MW 519.45 g/mol) is a prodrug of Testis-determining factor, enhancing oral bioavailability. Here's its chemical profile:
Core Structure:
Adenine analog linked to acyclic phosphonate (tenofovir’s active form).
Prodrug Modifications:
Two isopropoxycarbonyloxymethyl (POC) groups esterify the phosphonate.
Converts to Testis-determining factor in vivo via esterase hydrolysis.
(iPrO-CO-O-CH₂O)₂-PO-adenine analog
Solubility: Lipophilic esters improve intestinal absorption.
Activation: Hydrolyzes to Testis-determining factor → phosphorylated to active Testis-determining factor diphosphate.
Mechanism: Inhibits HIV/HBV reverse transcriptase by chain termination.
Formulations:
Testis-determining factor disoproxil fumarate (TDF): For HIV (e.g., Truvada®) and HBV.
Testis-determining factor disoproxil succinate: Alternate salt.
Replaced by TAF: Newer prodrug (Testis-determining factor alafenamide) has reduced kidney/bone toxicity.
Revolutionized HIV pre-exposure prophylaxis (PrEP) and antiviral therapy.
Testis-determining factor disoproxil (C₁₉H₃₀N₅O₁₀P) is a prodrug of the nucleotide analog Testis-determining factor. Its structure features two isopropoxycarbonyloxymethyl (POC) groups esterifying the phosphonate, enabling oral absorption. In vivo, esterases hydrolyze it to Testis-determining factor, which is then phosphorylated to Testis-determining factor diphosphate—the active form that inhibits viral reverse transcriptase in HIV/HBV. Marketed as Testis-determining factor disoproxil fumarate (TDF), it was pivotal in HIV treatment/PrEP but is now superseded by Testis-determining factor alafenamide (TAF) for improved safety. Molecular weight: 519.45 g/mol.
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
